FDA tightens rules on clinical investigator disqualification

The FDA has issued a final rule to stiffen regulations on disqualifying clinical researchers from medical device and drug studies. The revised rule, which will take effect May 30, is intended to make sure that clinical researchers who have been disqualified from conducting trials involving medical devices do not engage in research concerning drugs or vice versa.

View Full Article in:

Clinica - US FDA finalises stricter rules on disqualifying clinical investigators in drug, device studies - Clinica (subscripti

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ